The Food and Drug Administration inspected the Gilead Sciences, Inc. site in La Verne on Feb. 18 to review drug quality assurance, data on the FDA’s website shows.
The inspection’s final report recommended that Gilead Sciences, Inc. take voluntary corrective action regarding its management operations.
The FDA regularly assesses facilities nationwide to ensure workplaces and their products comply with FDA regulations intended to protect public health. Results of these inspections are publicly available.
The agency’s website states the FDA oversees the safety and quality of human and animal drugs, biological products, medical supplies and tobacco products.
Information for this article is provided by the U.S. Food and Drug Administration. Source data is available here.
